Skip to main content
. 2020 May 12;13(2):491–496. doi: 10.1159/000507345

Table 1.

Patient demographics/treatment

Age, years Gender Site Stage Metastasis Previous TXT Duration anti-PD-L1, months
48 m prostate IV bone, lymph nodes radiation 4
66 m lung III adjuvant cisplatin/Alimta 4
72 m lung III adjuvant carboplatin/Taxol 10
59 m lung IV lung na 4
69 m lung IV lung carboplatin/Etopophos 9
71 m urothel IV lymph nodes na 4
HHS Vulnerability Disclosure